Facts
- HQ
- United States
- Sectors
- Higher Education
- Founded
- 1876
Is this your organization? Claim it
Fred Hutch-Led Synthesize Bio Raises $10M to Accelerate Drug Discovery Using AI Gene Expression Model
Seattle-based Synthesize Bio, led by Fred Hutchinson Cancer Center researchers, raised $10 million from Madrona to accelerate drug discovery using their AI model GEM-1, which predicts gene expression outcomes with lab-level accuracy. The startup aims to reduce drug development time and costs by simulating hypothetical lab experiments with generative genomics.
GeekWire Awards Health Innovation Finalists Spotlight Cancer-Fighting Biotechs Including Archon Biosciences with $20M AI-Driven Protein Therapy
The GeekWire Awards finalists for Health Innovation of the Year primarily consist of companies developing advanced cancer-fighting technologies, alongside startups improving healthcare management. Notable finalists include Archon Biosciences, which recently secured $20 million to develop AI-optimized protein therapies, Fred Hutch Cancer Center, and others.
Seattle-Area Longevity Biomedical to Go Public via SPAC in Q2 2023, Raising $30M with $236M Valuation
Longevity Biomedical, formed by merging Seattle-area startups Cerevast Medical, NovoKera, and Aegeria Soft Tissue, plans to go public via a SPAC merger expected to close in Q2 2023, raising at least $30 million. The combined company targets healthspan extension with treatments for stroke, blindness, and soft-tissue reconstruction, and is valued at $236.2 million.
Erin Papworth
Erin Papworth is the CEO and Co-Founder of Nav.it, the social and finance app that helps young earners find their personalized way to increased wealth. A two-time entrepreneur, she spent over a decade living and working overseas, managing multi-million dollar programs and working for organizations like Johns Hopkins University, Doctors without Borders, the United Nations, and the United States Government. During that time, Erin experienced firsthand the decline of societies when young people have limited access to credit and financial markets. She became passionate about increasing access to financial system for marginalized population in order to help them grow intergenerational…
Rose Health wins Cambia Grove’s TRAILS competition; to develop platform with Providence Digital Innovation Group and MultiCare
Baltimore-based mental health startup Rose Health won the TRAILS behavioral-health startup competition hosted by Seattle’s Cambia Grove, earning a partnership to develop its platform with Providence Digital Innovation Group and MultiCare Behavioral Health Network. Founded by CEO Kavi Misri and recently raising $1.7 million in seed funding, Rose offers patient self-care tools and a clinician dashboard with behavioral specialists supporting each healthcare customer.
OfferUp hires Melissa Binde as CTO; Amazon data-center leader Joe Minarik joins DataBank as COO; senior tech moves at Goldman and Microsoft
OfferUp hired former Splunk VP of Engineering Melissa Binde as CTO, succeeding Ameesh Paleja; Joe Minarik left Amazon after 16 years to become DataBank COO, and several senior tech leaders moved between major firms including Anthony Penta to Goldman Sachs and Mike Filippo from Apple to Microsoft.
Curi Bio raises $10M to advance iPSC-based 3D tissue drug-discovery platforms including Mantarray
Seattle-based Curi Bio raised $10 million in Series A financing to advance its human iPSC-based drug discovery platforms, including 3D engineered tissue products like Mantarray and Cytostretcher. The company provides customized assay and screening services for cardiac, musculoskeletal and neuromuscular models and has prior funding including $6M this spring and over $6M in NIH grants.
Seattle-area CaaMTech Raises $22M to Develop Novel Tryptamines, Aiming for Human Testing
Seattle-area startup CaaMTech raised $22 million to develop synthesized tryptamine compounds similar to those in psilocybin and LSD, aiming to create defined formulations that maximize desired psychedelic effects and minimize side effects. The company says many of its novel agents are unscheduled in the U.S., and it plans to advance toward human testing amid growing investment and interest in psychedelics for mental-health treatments.
Brothers David and Connor Wallace launch CODA Farm Technologies to bring IoT irrigation to their historic Wallace potato farm
Brothers David and Connor Wallace left tech jobs to found CODA Farm Technologies, an IoT agriculture startup built from their multigenerational Wallace potato farm in Skagit Valley. The company focuses on applying David’s data-science and Connor’s software skills to irrigation and other farm problems using connected devices.
Curi Bio raises $6M Series A led by Dynamk Capital to advance human stem cell drug-discovery platforms
Seattle stem-cell startup Curi Bio raised $6 million in a Series A led by Dynamk Capital to advance its human stem cell platforms for drug discovery, bringing total funding to $16.8 million.
University of Washington launches Husky FAST Start to standardize licensing for spinouts after 35-startup pilot
The University of Washington launched Husky FAST Start, a standardized licensing process with template term sheets and agreements to speed and cut costs for startup license negotiations, after piloting it with 35 startups. The move, timed with the Bayh-Dole Act’s 40th anniversary, aims to help UW founders commercialize innovations from a university that has spun out 73 startups in five years and signed over 5,000 commercial licenses.
